Compounds > technetium tc 99m sestamibi
Page last updated: 2024-08-16

technetium tc 99m sestamibi and Cushing Syndrome

technetium tc 99m sestamibi has been researched along with Cushing Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balasubramanian, SP; Debono, M; Edafe, O; Tahir, F1
Gierach, M; Junik, R; Pilecki, S; Pufal, J1

Other Studies

2 other study(ies) available for technetium tc 99m sestamibi and Cushing Syndrome

ArticleYear
Simultaneous presentation of parathyroid carcinoma, papillary thyroid cancer and ACTH-independent hypercortisolism due to benign cortical adenoma.
    BMJ case reports, 2019, Sep-05, Volume: 12, Issue:9

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Carcinoma; Cushing Syndrome; Female; Humans; Hyperparathyroidism, Primary; Microscopy, Acoustic; Middle Aged; Neoplasms, Multiple Primary; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed

2019
The case of Cushing's disease imaging by SPECT examination without manifestation of pituitary adenoma in MRI examination.
    Nuclear medicine review. Central & Eastern Europe, 2005, Volume: 8, Issue:2

    Topics: Adenoma; Adult; Cushing Syndrome; False Negative Reactions; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2005